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Background and methods: A nano calcium-deficient hydroxyapatite (n-CDHA)-multi(amino 
acid) copolymer (MAC) composite bone substitute biomaterial was prepared using an in situ 
polymerization method. The composition, structure, and compressive strength of the composite 
was characterized, and the in vitro degradability in phosphate-buffered solution and preliminary 
cell responses to the composite were investigated.
Results: The composite comprised n-CDHA and an amide linkage copolymer. The compressive 
strength of the composite was in the range of 88–129 MPa, varying with the amount of n-CDHA 
in the MAC (ranging from 10 wt% to 50 wt%). Weight loss from the composite increased (from 
32.2 wt% to 44.3 wt%) with increasing n-CDHA content (from 10 wt% to 40 wt%) in the MAC 
after the composite was soaked in phosphate-buffered solution for 12 weeks. The pH of the 
soaking medium varied from 6.9 to 7.5. MG-63 cells with an osteogenic phenotype were well 
adhered and spread on the composite surface. Viability and differentiation increased with time, 
indicating that the composite had no negative effects on MG-63 cells.
Conclusion: The n-CDHA-MAC composite had good cytocompatibility and has potential to 
be used as a bone substitute.
Keywords: calcium deficient hydroxyapatite, multi(amino acid) copolymer, biocomposite, 
degradability, cytocompatibility
Introduction
For bone tissue substitute and repair, it is known that a biocomposite containing a 
bioceramic such as hydroxyapatite and a polymer normally possesses both   bioactivity 
(ceramic) and ductility (polymer).1–3 Hence, in designing a new inorganic/organic 
biocomposite, the choice of an inorganic component and a polymer are key to formu-
lating a composite with favorable bioperformance. Nano hydroxyapatite biomateri-
als have being extensively developed for biomedical applications in recent decades 
because they have good biocompatibility and bioactivity, and can bond with host 
bone directly.3–5 However, nano hydroxyapatite, with an atomic molar Ca/P ratio 
of 1.67, is very stable and hence shows poor degradability in vivo, which greatly 
limits its clinical   application.6 Recently, an increasing number of studies have been 
focusing on the development of nano calcium-deficient hydroxyapatite (n-CDHA, 
Ca10−X(HPO4)X(PO4)6−X(OH)2−X, 0 # x , 1).6–10 Compared with nano hydroxyapatite, 
CDHA has higher solubility (ie, degradability) at a lower Ca/P ratio (1.5–1.67), 
as well as being more similar in composition and crystal structure to the mineral 
of natural bone.7–9 Thus, n-CDHA is a better candidate as the inorganic phase of a 
degradable biocomposite.
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Degradable polymers have been extensively investigated 
as biomaterials due to their favorable biocompatibility and 
degradation properties, their absorbability in vivo, and ability 
to disappear eventually with time.11–13 a-L-amino acids and 
glycine are the basic units of proteins.14 Poly(amino acid)s 
and copolymers based on such amino acids are favorable 
for use in tissue engineering, drug release, and regenerative 
  medicine.11 However, these polymers generally have poor 
thermal stability, and poor processing and mechanical 
  properties, so have limited biomedical applications. ω-amino 
acid has a structure similar to that of a L-amino acid and its 
polymer, polyamide, which has excellent mechanical and 
processing properties, as well as good biocompatibility. 
  However, polyamide is not degradable because of its high 
crystallinity and the strong actions of the hydrogen bonds 
existing in its macromolecular structure. Therefore, it is 
expected that addition of a-L-amino acids to poly (ω-amino 
acid)s could change the polymeric molecular structure and   
improve degradability. Studies have reported the synthesis and 
properties of copolymers consisting of 6-aminocaproic acid 
and a-L-proline, 6-aminocaproic acid and L-leucine. How-
ever, these polymers show a low rate of degradability, with 
only 6–10 wt% being lost after 4 weeks of soaking.14,15
Recently, a multi(amino acid) copolymer (MAC) 
  consisting of 6-aminocaproic acid and five amino acids 
was developed in our laboratory. This copolymer could be 
degraded in HCL-Tris solution with weight loss of about 
30 wt% after 12 weeks of soaking.16 In particular, our results 
show that during the degradation period, this copolymer had 
no significant effect on the pH of the ambient environment 
and maintained a complete structure and adequate mechanical 
strength compared with other degradation polymers, such as 
polylactic acid and it copolymers. Cell culture experiments 
and in vivo implantation results show that the copolymer 
also had good biocompatibility. Thus, the composite of the 
copolymer with n-CDHA is a new biomaterial with poten-
tial medical applications. The purpose of this study was to 
prepare a novel composite composed of n-CDHA and MAC. 
In addition, the in vitro degradability of the n-CDHA-MAC 
composite in phosphate-buffered solution and preliminary 
cell responses to the composite were investigated.
Materials and methods
Synthesis of n-CDHA-MAC composite
n-CDHA was prepared as already described in the pub-
lished literature.17 The n-CDHA-MAC composite was 
synthesized using an in situ polymerization method. Six 
grams of alanine, 7 g of phenylalanine, 1 g of glycine, 105 g 
of 6-aminocaproic acid, 6 g of proline, 2 g of lysine, and 
n-CDHA slurry (5 g n-CDHA/100 mL water) were added 
to a three-necked flask with continuous stirring. The reac-
tion system was heated using an oil bath. The mixture was 
heated to 200°C for about 2 hours until the water was fully 
evaporated, and the mixture was melted. The system was 
then kept at 21°C for 2 hours and then at 220°C for one 
hour. After cooling to room temperature, the target com-
posites were obtained. The reaction system was protected 
by a continuous flow of nitrogen gas to avoid undesirable 
oxidation reactions. The MAC was prepared by the same pro-
cedure without addition of n-CDHA, and used as a control. 
Composites with 10 wt%, 20 wt%, 30 wt%, 40 wt%, and 
50 wt% n-CDHA were prepared and named as 10CDHA-
MAC, 20CDHA-MAC, 30CDHA-MAC, 40CDHA-MAC, 
and 50CDHA-MAC, respectively.
Characterization of n-CDHA-MAC 
composite
The morphology of n-CDHA was observed under a trans-
mission electron microscope (JEM-100CX; JEOL, Tokyo, 
Japan). The atomic molar ratio of Ca/P was analyzed by 
inductively coupled plasma atomic emission spectroscopy 
(IRIS 1000; Thermo Elemental, Franklin, MA). The compo-
sition and structure of the 30CDHA-MAC composite were 
characterized by Fourier transform infrared spectroscopy 
(170SX FT-IR Spectrometer; Nicolet, Madison, WI) and 
X-ray diffraction (X’Pert pro-MPD; Philips, Eindhoven,   
The Netherlands). To observe the n-CDHA distribution in 
MAC matrices, the 30CDHA-MAC composite was frac-
tured in liquid   nitrogen, and a cross-sectional specimen was 
observed under a scanning electron microscope (Hitachi 
S-450). In addition, the effects of the amount of n-CDHA on 
the compressive strength of the composite were assessed in 
the composite samples (Φ 10 × 12 mm) containing different 
amounts of n-CDHA (0 wt%, 10 wt%, 20 wt%, 30 wt%, 
40 wt%, and 50 wt%) using a mechanical testing machine 
(REGER 30–50; Shenzhen Reger Co, Ltd, Shenzhen, 
China) with 50 kN load cells. The cross-head speed was 
5 mm/minute, and the load was applied until the specimens 
were compressed to about 20% of their original height. Five 
replicates were carried out for each group, and the results 
are expressed as the mean ± standard deviation.
In vitro degradability
The in vitro degradability of the composite was performed by 
soaking the samples (Φ 12 × 2 mm) in phosphate-buffered 
solution (pH = 7.4) for 12 weeks. After being washed with 
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purified water and dried, the samples were weighed [the 
initial weight (W0)], and then soaked in phosphate-buffered 
solution with a solid/liquid mass ratio of 1 g/100 mL in PE 
tubes. The tubes were capped and placed in a shaking water 
bath (37°C and 72 rpm), and the phosphate-buffered solu-
tion was replenished every week. The samples were washed 
and dried at weeks 1, 2, 4, 8, and 12, and the residual weight 
was calculated (Wt). The weight loss ratio was calculated 
according to the following equation:
  weight loss (%) = 100 (W0 − Wt)/W0
The pH of the the phosphate-buffered solution was 
  measured before being refreshed using an electrolyte-type pH 
meter (PS-25, Leici Instrument Factory, Shanghai, China).
Cytocompatibility
MG-63 osteoblast-like cells were cultured in Dulbecco’s 
Modified Eagle Medium supplemented with 10% fetal bovine 
serum plus 100 U/mL penicillin and 100 µg/mL streptomycin 
sulfate at 37°C in a humidified 5% CO2 atmosphere. The 
cells were incubated in 25 cm2 flasks to reach 80% conflu-
ence and were then detached for further experiments. The 
30CDHA-MAC composite and MAC samples with a size 
of Φ 12 × 2 mm were used for all the cell culture experi-
ments, and a tissue culture plate was used as the control. 
The samples were sonicated in ethanol and sterilized using 
ethylene oxide gas.
Cell adhesion
To investigate cell adhesion on the samples, MG-63 cells 
at a density of 2 × 104 cells/well were seeded onto samples 
located in 24-well tissue culture plates. The cells were 
allowed to adhere for one hour, after which each well was 
gently flooded with 1 mL medium. The cell and samples were 
cultured at 37°C and CO2 5% in a humidified atmosphere 
for 4 hours, and the unattached cells were then removed by 
washing with phosphate-buffered solution three times. After 
the cells attached to the samples were digested by trypsin, 
the adherent cells were counted using a hemacytometer, and 
cell attachment efficiency was determined by counting the 
number of cells remaining in the wells. Five replicates were 
carried out for each sample, and the results were expressed 
as the mean ± standard deviation.
Cell viability
The viability of MG-63 cells on the samples was determined 
using the MTT (3-{4,5-dimethylthiazol-2yl}-2,5-diphenyl-
2H-tetrazolium-bromide) assay. MTT measures changes in 
absorbance at a specific wavelength and is widely used for 
measuring cytotoxicity and cell viability. The production of 
purple formazan in osteoblast cultures with or without the 
samples was measured after days 1, 3, 5, and 7 of incubation 
in 24-well culture plates. For this purpose, 100 µL of MTT 
(MajorBiochem, Shanghai, China) solution (5 mg/mL) was 
added to each well (containing either cells alone or pellets 
with adherent cells removed from the original culturing 
well) and the cells were incubated for 4 hours. Subsequently, 
the culture medium was aspirated and dimethyl sulfoxide 
1000 µL/well was added to dissolve the formazan com-
pletely for 10 minutes at 37°C. Then 100 µL of solution 
was transferred to a 96-well enzyme-linked immunosorbent 
assay plate and the absorbance was measured at 490 nm 
using a microplate reader (Multiskan MK3, Thermo Electron 
  Corporation, Waltham, MA).
Alkaline phosphatase activity
MG-63 cells were seeded onto the samples and the alkaline 
phosphatase (ALP) activity of the cells was measured at 
different times. After 7 days, the culture medium in the 
24-well plates was aspirated, and 200 µL of 1% Nonidet 
P-40 solution was added to each well at room temperature 
and incubated for one hour. The cell lysate was obtained and 
centrifuged, after which 50 µL of supernatant was added to 
96-well plates; 50 µL of 2 mg/mL p-nitrophenyl phosphate 
(Sangon, Shanghai, China) substrate solution composed of 
0.1 mol/L glycine and 1 mmol/L MgCl2 ⋅ 6H2O was added 
and incubated for 30 minutes at 37°C. The reaction was 
quenched by addition of 100 µL of 0.1 N NaOH, and the 
ALP absorbance was quantified at the wavelength of 405 nm 
using a microplate reader (SPECTRAmax 384, Molecular 
Devices, Sunnyvale, CA). Total protein content in the cell 
lysate was determined using the bicinchoninic acid method 
in aliquots of the same samples using the Pierce protein assay 
kit (Pierce Biotechnology Inc, Rockford, IL), read at 560 nm 
and calculated according to a series of bovine serum albumin 
standards. ALP levels were normalized to the total protein 
content at the end of the experiment.
Cell morphology
The morphology of the MG-63 cells cultured on the 
composite samples was observed by scanning electron 
microscopy. At days 3 and 5, the samples were removed 
and washed with phosphate-buffered solution twice and 
fixed in 2.5% glutaraldehyde in 0.1 M phosphate-buffered 
solution for 30 minutes. Thereafter, the fixed cells were 
washed with phosphate-buffered solution three times, and 
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then   dehydrated in ascending concentrations of ethanol (50, 
60, 70, 80, 90, and 100%, v/v) for 5 minutes. The specimens 
were prepared by first immersing them in 50% alcohol-
  hexamethyldisilazane solution (v/v) for 10 minutes, and 
then in pure hexamethyldisilazane for 10 minutes. Later, 
the samples were vacuum-dried at 37°C overnight, and the 
morphology of the MG-63 cells in the samples was observed 
using a scanning electron microscope.
Statistical analysis
Statistical analysis was conducted using one-way analysis 
of variance with post hoc Tukey’s tests. The results were 
expressed as the mean ± standard deviation. A value of 
P , 0.05 was considered to be statistically significant.
Results and discussion
Morphology of n-CDHA
A transmission electron microscopic image of n-CDHA is 
shown in Figure 1. It can be seen that the n-CDHA crystals 
were needle-like with an approximate size of about 40–80 nm 
in length and 20–40 nm in diameter. The Ca/P molar ratio 
of the n-CDHA was 1.52, as determined by inductively 
coupled plasma atomic emission spectroscopy. Therefore, 
the   specimen prepared was calcium-deficient hydroxyapatite 
[Ca9.12(HPO4)0.88(PO4)5.12(OH)1.12, x = 0.88] according to the 
formula of nonstoichiometric hydroxyapatite:
  (Ca10−X(HPO4)X(PO4)6−X(OH)2−X, 0 # x , 1).
Some studies have suggested that variation in the molar 
ratio of calcium to phosphate greatly affects the solubility 
of Ca-P biomaterials, and calcium phosphate with a Ca/P 
of 1.50 degraded faster than hydroxyapatite with a Ca/P of 
1.67 when implanted in vivo.7–9 Previous studies have shown 
that deficient calcium apatite, also called nonstoichiometric 
apatite, with a Ca/P of 1.50 was biologically more active 
than hydroxyapatite with a Ca/P of 1.67 because it has a 
composition and structure very close to that of natural bone 
mineral.9 Thus, it is envisaged that n-CDHA can be fabricated 
as a novel bone regeneration material in order to get better 
bioperformance of apatite biomaterial.
Infrared analysis
Figure 2A is the infrared spectrum of the multi(amino acid) 
copolymer. The peak at 3309 cm−1 is the nitrogen-hydrogen 
(NH) stretching vibration peak, and the bands around 
2935 cm−1 and 2861 cm−1 are attributed to carbon hydrogen 
(CH2) vibration peaks. The band at 1546 cm−1 represents the 
stretching vibration of carbon-nitrogen (CN). The band at 
1644 cm−1 is carbonyl vibration (C=O). These peaks indicate 
an amide copolymer structure. The Fourier transform infrared 
spectrum for n-CDHA is shown in Figure 2B. The peaks at 
3572 cm−1 and 605 cm−1 represent the vibration of the hydroxyl 
(OH) group, and the peaks at 561 cm−1, 1030 cm−1, and 
1101 cm−1 belong to PO4
3−. As shown in Figure 2C, the peaks 
of hydroxyl of n-CDHA and those of the copolymer exist in 
the composite, indicating that the composite was composed of 
n-CDHA and multi(amino acid) copolymer. However, some 
peaks varied and moved to 3567 cm−1 (OH), 3303 cm−1(NH), 
2936 cm−1(CH2), 2862 cm−1(CH2), 1544 cm−1(CN), and 
1640 cm−1 (C=O). This might be because of amide-calcium-
amide linkage and the hydrogen bond formed between 
n-CDHA and the copolymer.18 The interaction at the interface 
between the polymer and inorganic mineral has been shown to 
have positive effects on the mechanical properties and distribu-
tion of inorganic particles in the composite.18,19
Figure  1  Transmission  electron  microscopic  image  of  nano  calcium-deficient 
hydroxyapatite.
200
150
100
50
3567
3303
3572
3309
1644
A
B
C
1640 1544
1546
4000 3500 3000 2000
Wavenumber (cm−1)
T
r
a
n
s
m
i
t
t
a
n
c
e
 
 
(
%
)
1500 1000 500 2500
0
Figure  2  Infrared  spectra  of  multi(amino  acid)  copolymer  (A),  nano  calcium-
deficient hydroxyapatite (B), and 30 wt% nano calcium-deficient hydroxyapatite-
multi(amino acid) polymer composite (C).
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X-ray diffraction analysis
Figure 3 shows the X-ray diffraction patterns for n-CDHA, 
multi(amino acid) copolymer, and the composite with 30 wt% 
n-CDHA. The peaks at 2θ = 20° and 23.8° are attributed 
to the MAC (Figure 3A). The peaks at 2θ = 25.7°, 31.6°, 
32.7°, 33.8°, 40°, 47.1°, 49.8°, and 53° shown in Figure 3B 
indicate an apatite structure. All the aforementioned peaks 
were present in the composite, and no new peaks were found 
(Figure 3C). Hence, X-ray diffraction analysis results also 
show that the composite was composed of n-CDHA and the 
MAC. The peak intensities of MAC obviously decreased in 
the composite, as shown in Figure 3C. This change indicated 
that the presence of n-CDHA had significant effects on the 
crystallinity of the copolymer. This most likely resulted 
from the addition of n-CDHA to the composite, hindering 
the formation of hydrogen bonds in the molecular chain of 
the copolymer, and hence decreasing the regularity in the 
molecular chain.
n-CDHA distribution in MAC
The n-CDHA particle distribution in the composite shown 
in Figure 4 indicates that the n-CDHA particles were homo-
geneously dispersed in the MAC matrix, suggesting that the 
n-CDHA was still of a nanometer scale in the composite 
and that few agglomerations occurred during the synthesis 
process. Some n-CDHA particles were exposed on the 
composite surfaces, which was in favor of cell adhesion on 
the composite.
Mechanical properties
In general, the inorganic filler content in a polymer has 
  obvious effects on the mechanical properties of an   inorganic/
organic composite. In the present study, the effects of 
  varying amounts of n-CDHA on the compressive strength 
of the composite are shown in Figure 5. It was found that 
the compressive strength of the n-CDHA-MAC composites 
ranged from 88 MPa to 129 MPa, which is close to that of 
natural cortical bone tissue (around 50–140 MPa),20 and 
increased with increasing amounts of n-CDHA in the com-
posite (from 10 wt% to 40 wt%). No significant difference 
in compressive strength was found between the MAC and 
the 10CDHA-MAC (P . 0.05) and 30CDHA-MAC and 
40CDHA-MAC composites (P . 0.05). However, when the 
content of apatite in the polymer was 50 wt%, the compres-
sive strength of the composite decreased significantly as 
compared with the 40CDHA-MAC composite (P , 0.05), 
and the samples were collapsed, exhibiting brittleness. The 
results indicate that the n-CDHA-MAC composite with 
30 wt% or 40 wt% amounts of apatite in the polymer had 
higher mechanical strength.
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Figure  3  X-ray  diffraction  patterns  of  multi(amino  acid)  copolymer  (A),  nano 
calcium-deficient  hydroxyapatite  (B),  and  30  wt%  nano  calcium-deficient 
hydroxyapatite-multi(amino acid) copolymer composite (C).
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Figure  4  Cross-sectional  morphology  of  30  wt%  nano  calcium-deficient 
hydroxyapatite-multi(amino acid) copolymer composite.
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Figure 5 Effects of nano calcium-deficient hydroxyapatite (n-CDHA) contents on 
the  compressive  strength  of  nano  calcium-deficient  hydroxyapatite-multi(amino 
acid) copolymer composite.
Note: *P , 0.05.
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Degradation in phosphate-buffered 
solution
Figure 6 shows the degradability of the n-CDHA-MAC 
composite soaked in phosphate-buffered solution over time. 
It was found that weight loss from both MAC and the com-
posite increased in phosphate-buffered solution with time, 
indicating that the samples were degradable. In addition, 
weight loss from the composite increased according to the 
n-CDHA content in the polymer. When the n-CDHA content 
was 20 wt%, weight loss from the composite was signifi-
cantly higher than from the MAC (P , 0.05). No significant 
difference was found in the extent of weight loss between the 
MAC and 10CDHA-MAC. After 12 weeks of immersion, 
weight loss from the 30CDHA-MAC and 40CDHA-MAC 
composites reached 41.5 wt% and 44.3 wt%. However, the 
40CDHA-MAC samples were degraded after soaking for 
8 weeks.
Generally, the dissolution behavior of n-CDHA is mainly 
dependent on the molar ratio of Ca/P. n-CDHA with a lower 
ratio shows better solubility. In our study, the Ca/P molar ratio 
of n-CDHA was 1.52, indicating that it had good solubility. 
In addition, the nanoparticles were uniformly distributed in 
the polymer matrix. When the composite was incubated in 
soaking medium, the polymer first degraded and then the 
nanoparticles could be dissolved. Obviously, dissolution of 
the composite was faster than degradation of the polymer, 
and weight loss from the n-CDHA-MAC composite reflected 
degradation of both the n-CDHA and MAC.
However, addition of nanoparticles to a degradable 
polymer can also alter the degradation behavior by, eg, 
  increasing hydrophilicity and decreasing crystallinity.21 For 
the n-CDHA-MAC composite, when the nanoparticles were 
dissolved in the soaking medium and micropores were formed, 
the erosion surface of the MAC increased, indicating a higher 
degradation rate than that of pure MAC. Moreover, our X-ray 
diffraction results show that addition of n-CDHA decreased 
the crystallinity of MAC compared with the pure specimen, 
which also had an increased degradation rate because the 
amorphous region of a semicrystalline polymer undergoes 
faster degradation, as a result of a higher rate of water uptake 
in the free volume than in the crystalline regions.22
Generally, implants which are degradable in vivo with 
an appropriate degradation rate allow host tissue growth 
until healing is complete, while eliminating the need for a 
second operation to remove the implant.11,23 In this study, 
the n-CDHA-MAC composites with 30 wt% and 40 wt% 
exhibited suitable degradation in phosphate-buffered solu-
tion over time, and the mechanical strength of the 30 wt% 
n-CDHA composite was higher than that of the 40 wt% 
specimen after soaking for 12 weeks. Therefore, it could be 
suggested that the composite with 30 wt% n-CDHA has the 
potential to provide enough mechanical strength to meet the 
fundamental requirements of a bone substitute.
pH change of the soaking solution
The changes in pH of the phosphate-buffered solution after 
soaking the n-CDHA-MAC composite and MAC for different 
time periods are shown in Figure 7. pH increased slightly 
with increasing amounts of n-CDHA in the n-CDHA-MAC 
composites during soaking of the samples over 12 weeks. 
In the case of the MAC, the pH gradually increased from 
6.9 to 7.1 over 12 weeks of soaking, whereas the pH   gradually 
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rose from 6.9 and stabilized at 7.3 for the CDHA-MAC 
composites. During incubation in the phosphate-buffered 
solution, the amide bonds were cleaved for hydrolysis and 
degraded into oligomers and eventually into monomers. 
These amino acid monomers, with the exception of lysine, 
show weak acidity in liquid solution because there is more 
H+ formed by the carboxyl groups than those bound by the 
amino groups, resulting in a pH decrease in the soaking 
medium. Therefore, the higher the degradation rate, the 
lower the pH value. When the degradation rate decreased, 
pH gradually increased. In addition, the pH of the composite 
was higher than that of the MAC. This may be attributed to 
the weakly alkaline nature of n-CDHA.
The pH of the physiological environment after biomaterials 
are implanted in vivo would greatly influence the interactions 
between cells and implants via cellular responses. Some 
researchers have shown that an acidic (low pH) environment 
might be clinically undesirable for cell survival.24 For degrad-
able polymeric materials like polylactic acid, the acidic 
byproducts of degradation result in a decrease in the pH of 
the ambient environment, and hence induce an inflammatory 
reaction after implantation in vivo.25 In this study, the pH of 
the soaking solutions varied from 6.9 to 7.5, indicating that 
degradation byproducts of the n-CDHA-MAC composite 
had little effect on the pH of the phosphate-buffered solu-
tion, and therefore were unlikely to have adverse effects on 
cells in vivo.
Cytocompatibility
Cell adhesion
After 4 hours of culture, cell adhesion on the n-CDHA-MAC 
composite was investigated using MG-63 cells, MAC, and 
a tissue culture plate as the control. Over 4 hours, the cell 
adhesion rate on the composite was 117%, on the MAC was 
108%, and for the tissue culture plate was 100%. The results 
show that the cell adhesion rate for the n-CDHA-MAC 
composite was higher than for the control, indicating that 
incorporation of n-CDHA into MAC facilitated cell adhesion 
on the composite.
Adhesion is part of the first phase of cell-material 
interaction, and the quality of this first phase will influence 
the cell’s capacity for growth, morphology, proliferation, 
and differentiation upon contact with the implant.26 The 
cell adhesion results of this study indicate that MG-63 
osteoblast-like cells adhered better to the n-CDHA-MAC 
composite with 30 wt% n-CDHA than to the MAC and to 
the tissue culture plate control within the first 4 hours. The 
superior ability of MG-63 cells to attach to the composite 
probably reflects the differing material surface features of the 
composite and the MAC. The nanosized calcium-deficient 
hydroxyapatite in the MAC expose the composite surfaces 
that had additional surface properties, which improved cell   
adhesion.26,27
Cell viability
The MTT assay was used to evaluate MG-63 cell viability on 
the 30CDHA-MAC composite because optical density values 
can provide an indicator of cell viability on biomaterials. It 
can be seen in Figure 8 that the optical density of the compos-
ite and the controls (MAC and tissue culture plate) increased 
significantly with time, suggesting that MG-63 cells were 
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multi(amino acid) copolymer (30CDHA/MAC) composite by MTT assay at 1, 3, 5 
and 7 days (MAC and tissue culture plate as controls).
Note: *P , 0.05.
Abbreviations: MAC, multi(amino acid) copolymer; TCP, tissue culture plate.
150
*
*
100
50
0
30CDHA/MAC
MAC
TCP
01 35
A
L
P
 
a
c
t
i
v
i
t
y
 
(
m
U
/
m
g
 
p
r
o
t
e
i
n
)
Time (day)
7
Figure 9 ALP activity of MG-63 cells cultured on 30 wt% nano calcium-deficient 
hydroxyapatite-multi(amino acid) copolymer (30CDHA/MAC) composite, multi(amino 
acid) copolymer (MAC), and tissue culture plate (TCP) as controls.
Note: *P , 0.05.
Abbreviation: ALP, alkaline phosphatase.
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viable on these samples, showing positive cellular responses 
to the composite and controls, with the composite having 
good cytocompatibility, similar to that of the controls.
There was no significant difference in optical   density 
between the composite and controls at days 1 and 7.   However, 
the optical density of the CDHA-MAC composite was higher 
than for the MAC and tissue culture plate at 3 and 5 days 
(P , 0.05), indicating that the composite could improve cell 
viability and that the biological properties of the composite 
were superior to those of the MAC. Ideally, bioactive bio-
materials need to interact actively with cells and stimulate 
cell growth. In this study, the optical density of the n-CDHA 
composite was significantly higher than that of the MAC at 
3 and 5 days, indicating that the composite could enhance 
MG-63 osteoblast-like cell growth. Therefore, it could be 
suggested that the n-CDHA in the composite might be 
responsible for stimulating cell growth.26,28
ALP activity
The ALP activity of MG-63 cells cultured on the 30CDHA-
MAC composite and the controls (MAC and tissue culture 
plate) was determined at days 1, 3, 5, and 7, and the results are 
shown in Figure 9. The ALP activity of MG-63 cells cultured 
on the composite and controls increased over time, with no 
significant difference found at days 1, 3, and 5. However, 
ALP activity in the cells on the composite was significantly 
higher than that of controls at 7 days (P , 0.05).
ALP is an enzyme secreted by osteoblasts and is a marker 
of osteoblastic phenotype and mineralization.29 In this study, 
the composite containing 30 wt% n-CDHA showed signifi-
cantly higher levels of ALP expression than did the MAC and 
tissue culture plate at 7 days, indicating that the cells differenti-
ated more quickly after being cultured on the composite than on 
the control. Therefore, the biggest advantage of the composite 
containing n-CDHA appears to be its superior ALP activity 
as compared with the MAC. This increased activity probably 
resulted from the n-CDHA in the composite, which might be 
responsible for stimulating cell differentiation.26,29–31
Cell morphology
Scanning electron microscopic images of MG-63 cells cul-
tured on the 30CDHA-MAC composite and the MAC for 
3 days are shown in Figure 10. At 3 days, the cells were well 
spread on both the composite and the MAC surfaces, and 
had a sheet shape because of inoculation after its viability. 
In addition, the cells extended out and formed a confluent 
layer with close attachment to both the composite and MAC 
surfaces, with more cells present on the composite than on 
the MAC surface. These results are consistent with those 
of previous studies, showing that the addition of calcium 
phosphate particles to a polymer improves the biological 
properties of composites and has positive effects on cell 
morphology and viability.29,32
Conclusion
The amount of n-CDHA in the copolymer had obvious 
effects on the compressive strength of the copolymer, and 
a composite containing 30 wt% n-CDHA showed good 
mechanical performance. Weight loss from the compos-
ite into phosphate-buffered solution increased with the 
n-CDHA content in the polymer, and the degradation 
byproducts of the composite had no significant effect on 
the pH of the soaking solution. The results demonstrate 
that introduction of n-CDHA into the MAC gave rise to a 
bioactive and more degradable n-CDHA-MAC composite, 
and that the n-CDHA in the composite improved adhesion, 
viability, and differentiation of MG-63 osteoblast-like cells. 
It can be suggested that incorporation of n-CDHA into MAC 
could enhance the biological properties of the composite. 
This composite had good cytocompatibility and could be 
used as a bioactive bone implant that might stimulate tissue 
regeneration.
Figure 10 Scanning electron microscopic images of MG-63 cells cultured on multi(amino acid) copolymer (A) and 30 wt% nano calcium-deficient hydroxyapatite-multi(amino 
acid) copolymer composite (B) for 3 days.
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